Year |
Citation |
Score |
2023 |
Adams F, Zimmermann CM, Baldassi D, Pehl TM, Weingarten P, Kachel I, Kränzlein M, Jürgens DC, Braubach P, Alexopoulos I, Wygrecka M, Merkel OM. Pulmonary siRNA Delivery with Sophisticated Amphiphilic Poly(Spermine Acrylamides) for the Treatment of Lung Fibrosis. Small (Weinheim An Der Bergstrasse, Germany). e2308775. PMID 38126895 DOI: 10.1002/smll.202308775 |
0.694 |
|
2023 |
Jin Y, Adams F, Isert L, Baldassi D, Merkel OM. Spermine-Based Poly(β-amino ester)s for siRNA Delivery against Mutated KRAS in Lung Cancer. Molecular Pharmaceutics. PMID 37578116 DOI: 10.1021/acs.molpharmaceut.3c00206 |
0.697 |
|
2023 |
Kandil R, Baldassi D, Böhlen S, Müller JT, Jürgens DC, Bargmann T, Dehmel S, Xie Y, Mehta A, Sewald K, Merkel OM. Targeted GATA3 knockdown in activated T cells via pulmonary siRNA delivery as novel therapy for allergic asthma. Journal of Controlled Release : Official Journal of the Controlled Release Society. 354: 305-315. PMID 36634709 DOI: 10.1016/j.jconrel.2023.01.014 |
0.734 |
|
2022 |
Baldassi D, Ngo TMH, Merkel OM. Optimization of Lung Surfactant Coating of siRNA Polyplexes for Pulmonary Delivery. Pharmaceutical Research. 1-15. PMID 36447020 DOI: 10.1007/s11095-022-03443-3 |
0.618 |
|
2022 |
Zimmermann CM, Baldassi D, Chan K, Adams NBP, Neumann A, Porras-Gonzalez DL, Wei X, Kneidinger N, Stoleriu MG, Burgstaller G, Witzigmann D, Luciani P, Merkel OM. Spray drying siRNA-lipid nanoparticles for dry powder pulmonary delivery. Journal of Controlled Release : Official Journal of the Controlled Release Society. 351: 137-150. PMID 36126785 DOI: 10.1016/j.jconrel.2022.09.021 |
0.766 |
|
2022 |
Baldassi D, Ambike S, Feuerherd M, Cheng CC, Peeler DJ, Feldmann DP, Porras-Gonzalez DL, Wei X, Keller LA, Kneidinger N, Stoleriu MG, Popp A, Burgstaller G, Pun SH, Michler T, et al. Inhibition of SARS-CoV-2 replication in the lung with siRNA/VIPER polyplexes. Journal of Controlled Release : Official Journal of the Controlled Release Society. 345: 661-674. PMID 35364120 DOI: 10.1016/j.jconrel.2022.03.051 |
0.775 |
|
2022 |
Conte G, Costabile G, Baldassi D, Rondelli V, Bassi R, Colombo D, Linardos G, Fiscarelli EV, Sorrentino R, Miro A, Quaglia F, Brocca P, d'Angelo I, Merkel OM, Ungaro F. Hybrid Lipid/Polymer Nanoparticles to Tackle the Cystic Fibrosis Mucus Barrier in siRNA Delivery to the Lungs: Does PEGylation Make the Difference? Acs Applied Materials & Interfaces. 14: 7565-7578. PMID 35107987 DOI: 10.1021/acsami.1c14975 |
0.661 |
|
2021 |
Ambike S, Cheng CC, Feuerherd M, Velkov S, Baldassi D, Afridi SQ, Porras-Gonzalez D, Wei X, Hagen P, Kneidinger N, Stoleriu MG, Grass V, Burgstaller G, Pichlmair A, Merkel OM, et al. Targeting genomic SARS-CoV-2 RNA with siRNAs allows efficient inhibition of viral replication and spread. Nucleic Acids Research. PMID 34928377 DOI: 10.1093/nar/gkab1248 |
0.633 |
|
2021 |
Baldassi D, Gabold B, Merkel O. Air-liquid interface cultures of the healthy and diseased human respiratory tract: promises, challenges and future directions. Advanced Nanobiomed Research. 1. PMID 34345878 DOI: 10.1002/ANBR.202000111 |
0.591 |
|
2021 |
Keil TW, Zimmermann C, Baldassi D, Adams F, Friess W, Mehta A, Merkel OM. Impact of crystalline and amorphous matrices on successful spray drying of siRNA polyplexes for inhalation of nano-in-microparticles. Advanced Therapeutics. 4. PMID 34337144 DOI: 10.1002/adtp.202100073 |
0.673 |
|
2021 |
Keil TWM, Zimmermann C, Baldassi D, Adams F, Friess W, Mehta A, Merkel OM. Impact of Crystalline and Amorphous Matrices on Successful Spray Drying of siRNA Polyplexes for Inhalation of Nano‐in‐Microparticles Advanced Therapeutics. 4: 2100073. DOI: 10.1002/adtp.202100073 |
0.73 |
|
2020 |
Keil TWM, Baldassi D, Merkel OM. T-cell targeted pulmonary siRNA delivery for the treatment of asthma. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. e1634. PMID 32267622 DOI: 10.1002/Wnan.1634 |
0.755 |
|
Show low-probability matches. |